The Wenckebach Phenomenon.

AV node ECG Mobitz type 1 Wenckebach atrioventricular block electrophysiology

Journal

Current cardiology reviews
ISSN: 1875-6557
Titre abrégé: Curr Cardiol Rev
Pays: United Arab Emirates
ID NLM: 101261935

Informations de publication

Date de publication:
2021
Historique:
received: 20 02 2020
revised: 08 04 2020
accepted: 28 04 2020
pubmed: 20 7 2020
medline: 20 4 2021
entrez: 20 7 2020
Statut: ppublish

Résumé

Medicine has many great pioneers, and in 1899, one such pioneer - Karel Frederik Wenckebach made a discovery which, even to this day, remains one of the fundamental concepts within electrophysiology. Since the Wenckebach Phenomenon was first described, the field of electrophysiology has developed at a rapid pace, allowing us to observe this behaviour, and its complexities, in many new ways. In a similar way, this chapter will illustrate Wenckebach behaviour across a spectrum of modalities from the 12 lead ECG, through to the intra-cardiac recordings from both electrophysiological studies and implantable cardiac devices. In doing so, we continue to shed light on the phenomenon first identified through Wenckebach's meticulous attention to detail some 120 years ago.

Identifiants

pubmed: 32682381
pii: CCR-EPUB-108274
doi: 10.2174/1573403X16666200719022142
pmc: PMC8142363
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

10-16

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

Eur Heart J. 2013 Aug;34(29):2281-329
pubmed: 23801822
Br Heart J. 1966 May;28(3):350-8
pubmed: 5936967
Ann Intern Med. 1999 Jan 5;130(1):58-63
pubmed: 9890852
Cardiol J. 2011;18(3):337-9
pubmed: 21660930
J Cardiovasc Electrophysiol. 2011 Nov;22(11):1256-62
pubmed: 21489031
Am J Cardiol. 2001 Nov 1;88(9):1018-20
pubmed: 11703999
Am Heart J. 1975 Jan;89(1):26-31
pubmed: 1109548
Can J Physiol Pharmacol. 1969 Aug;47(8):695-704
pubmed: 5806460
Br Heart J. 1946 Jan;8(1):6-16
pubmed: 18610024
Clin Cardiol. 2018 Mar;41(3):282-284
pubmed: 29460961

Auteurs

Simon P Hansom (SP)

University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, K1Y 4W7, Canada.

Mehrdad Golian (M)

University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, K1Y 4W7, Canada.

Martin S Green (MS)

University of Ottawa Heart Institute, 40 Ruskin Street, Ottawa, Ontario, K1Y 4W7, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH